The two faces of Rift Valley fever virus virulence factor NSs: The development of a vaccine and the elucidation of pathogenesis

scientific article published on 18 July 2016

The two faces of Rift Valley fever virus virulence factor NSs: The development of a vaccine and the elucidation of pathogenesis is …
instance of (P31):
editorialQ871232
scholarly articleQ13442814

External links are
P356DOI10.1080/21505594.2016.1213938
P932PMC publication ID5160437
P698PubMed publication ID27432532

P50authorHideki EbiharaQ54008242
P2093author name stringSatoko Yamaoka
P2860cites workRift Valley Fever: An Emerging Mosquito-Borne DiseaseQ38776944
NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinaseQ39195523
Toscana virus induces interferon although its NSs protein reveals antagonistic activityQ39652674
NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcriptionQ39960501
Rescue of infectious rift valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign geneQ40311587
Antigenic and genetic relationships among Rift Valley fever virus and other selected members of the genus Phlebovirus (Bunyaviridae).Q40447812
Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine developmentQ40814834
Novel approaches to develop Rift Valley fever vaccinesQ27027003
The S Segment of Punta Toro Virus (Bunyaviridae, Phlebovirus) Is a Major Determinant of Lethality in the Syrian Hamster and Codes for a Type I Interferon AntagonistQ27478045
Characterization of Rift Valley fever virus MP-12 strain encoding NSs of Punta Toro virus or sandfly fever Sicilian virusQ28486276
TFIIH transcription factor, a target for the Rift Valley hemorrhagic fever virus.Q33198557
Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylationQ33406230
Rift Valley fever virus(Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and preventionQ33960690
The pathogenesis of Rift Valley feverQ34191969
Rift Valley fever virus vaccine lacking the NSs and NSm genes is safe, nonteratogenic, and confers protection from viremia, pyrexia, and abortion following challenge in adult and pregnant sheepQ34221766
Rift Valley Fever Virus MP-12 Vaccine Is Fully Attenuated by a Combination of Partial Attenuations in the S, M, and L Segments.Q34475358
Rift Valley fever virusQ34971963
Evaluation of the Efficacy, Potential for Vector Transmission, and Duration of Immunity of MP-12, an Attenuated Rift Valley Fever Virus Vaccine Candidate, in Sheep.Q35902010
The dominant-negative inhibition of double-stranded RNA-dependent protein kinase PKR increases the efficacy of Rift Valley fever virus MP-12 vaccineQ36155392
Rift valley fever virus lacking the NSs and NSm genes is highly attenuated, confers protective immunity from virulent virus challenge, and allows for differential identification of infected and vaccinated animalsQ36484009
Safety and immunogenicity of recombinant Rift Valley fever MP-12 vaccine candidates in sheep.Q36501630
Molecular biology and genetic diversity of Rift Valley fever virusQ36652695
Rift Valley fever virus MP-12 vaccine encoding Toscana virus NSs retains neuroinvasiveness in miceQ37006803
Mutational Analysis of the Rift Valley Fever Virus Glycoprotein Precursor Proteins for Gn Protein Expression.Q37049951
Development of a RVFV ELISA that can distinguish infected from vaccinated animalsQ37321966
The risk of Rift Valley fever virus introduction and establishment in the United States and European UnionQ37433782
Attenuation of pathogenic Rift Valley fever virus strain through the chimeric S-segment encoding sandfly fever phlebovirus NSs or a dominant-negative PKR.Q37509225
Breaking the chain: Rift Valley fever virus control via livestock vaccinationQ37998608
A review of vaccine development and research for industry animals in KoreaQ38099839
P433issue8
P921main subjectRift Valley feverQ326638
pathogenesisQ372016
Rift Valley fever virusQ14276794
Rift Valley fever phlebovirusQ24809101
P304page(s)856-859
P577publication date2016-07-18
P1433published inVirulenceQ18712614
P1476titleThe two faces of Rift Valley fever virus virulence factor NSs: The development of a vaccine and the elucidation of pathogenesis
P478volume7

Search more.